Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Payables (2020 - 2025)

P3 Health Partners' Payables history spans 5 years, with the latest figure at $11.7 million for Q4 2025.

  • For Q4 2025, Payables rose 38.77% year-over-year to $11.7 million; the TTM value through Dec 2025 reached $11.7 million, up 38.77%, while the annual FY2025 figure was $11.7 million, 38.77% up from the prior year.
  • Payables reached $11.7 million in Q4 2025 per PIIIW's latest filing, up from $10.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $24.1 million in Q1 2022 to a low of $8.4 million in Q4 2024.
  • Average Payables over 4 years is $13.7 million, with a median of $12.0 million recorded in 2025.
  • Peak YoY movement for Payables: tumbled 57.95% in 2023, then surged 68.37% in 2025.
  • A 4-year view of Payables shows it stood at $11.5 million in 2022, then decreased by 24.94% to $8.7 million in 2023, then decreased by 2.55% to $8.4 million in 2024, then soared by 38.77% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Payables are $11.7 million (Q4 2025), $10.0 million (Q3 2025), and $14.8 million (Q2 2025).